Note 3 - Investment in Joint Ventures (Tables)

9 Months Ended

Sep. 30, 2012

The Company's Investment Balance in ICP [Table Text Block]

	September 30, 2012 (a)		December 31, 2011
Company’s investment balance in ICP	$	7,460	$	11,777
Plus:
Funding commitment for capital Improvements		500		1,000
The Company’s maximum exposure to loss related to ICP	$	7,960	$	12,777

	Quarter Ended						Year to Date Ended
	September 30, 2012			September 30, 2011			September 30, 2012			September 30, 2011
ICP’s Operating results:
Net sales (a)	$	47,813		$	62,123		$	164,804		$	174,697
Cost of sales and expenses (b)		(48,261	)		(67,858	)		(164,493	)		(184,900	)
Net income (loss)	$	(448	)	$	(5,735	)	$	311		$	(10,203	)

The Company's Equity in Earnings (Loss) of Joint Ventures [Table Text Block]

	Quarter Ended						Year to Date Ended
	September 30, 2012			September 30, 2011			September 30, 2012			September 30, 2011
ICP (30% interest)(a)	$	(134	)	$	(2,867	)	$	229		$	(5,101	)
DMI (50% interest)		4			37			(65	)		99
	$	(130	)	$	(2,830	)	$	164		$	(5,002	)

Schedule of Equity Method Investments [Table Text Block]

	September 30, 2012		December 31, 2011
ICP (30% interest) (a)	$	7,460	$	11,777
DMI (50% interest)		302		370
	$	7,762	$	12,147